Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Omega Reports Fourth Quarter and Full Year 2024 Results

In This Article:

Completed $340 Million in New Investments in Q4 2024
Issued $438M in Equity
Providing 2025 Adjusted FFO Guidance

HUNT VALLEY, Md., February 05, 2025--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the "Company" or "Omega") announced today its results for the quarter and year ended December 31, 2024.

FOURTH QUARTER 2024 AND RECENT HIGHLIGHTS

  • Net income for the quarter of $116 million, or $0.41 per common share, compared to $57 million, or $0.22 per common share, for Q4 2023.

  • Nareit Funds From Operations ("Nareit FFO") for the quarter of $196 million, or $0.68 per common share, on 287 million weighted-average common shares outstanding, compared to $129 million, or $0.50 per common share, on 257 million weighted-average common shares outstanding, for Q4 2023.

  • Adjusted Funds From Operations ("Adjusted FFO" or "AFFO") for the quarter of $214 million, or $0.74 per common share, compared to $173 million, or $0.68 per common share, for Q4 2023.

  • Funds Available for Distribution ("FAD") for the quarter of $202 million, or $0.70 per common share, compared to FAD of $163 million, or $0.64 per common share, for Q4 2023.

  • Completed approximately $340 million in Q4 new investments consisting of $179 million in real estate acquisitions and $162 million in real estate loans.

  • Issued 11 million common shares in Q4 for gross proceeds of $438 million.

  • Completed $26 million in new investments in Q1 2025 to date.

  • Repaid $400 million of senior unsecured notes due January 15, 2025.

  • In January 2025, submitted notification to extend the maturity date of its $1.45 billion unsecured revolving credit facility and its $50 million term loan to October 30, 2025.

FULL YEAR 2024 HIGHLIGHTS

  • Net income for 2024 of $418 million, or $1.55 per common share, compared to $249 million, or $1.00 per common share, in 2023.

  • Nareit FFO of $734 million, or $2.71 per common share, on 270 million weighted-average common shares outstanding, compared to $591 million, or $2.36 per common share, on 250 million weighted-average common shares outstanding, in 2023.

  • AFFO of $778 million, or $2.87 per common share, compared to $699 million, or $2.79 per common share, in 2023.

  • FAD of $739 million, or $2.73 per common share, compared to FAD of $657 million, or $2.62 per common share, in 2023.

  • Completed $1.1 billion in 2024 new investments, consisting of $696 million in real estate acquisitions, which includes the assumption of a $243 million mortgage loan, and $359 million in real estate loans.

  • Issued 34 million common shares for gross proceeds of $1.2 billion.

  • Repaid $400 million of senior unsecured notes due April 1, 2024.